Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bénédict Fallet & Ulrich A. Walker. (2020) Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies. Expert Review of Clinical Pharmacology 13:11, pages 1203-1218.
Read now
Read now
Christina G. Katsiari, Theodora Simopoulou, Ioannis Alexiou & Lazaros I. Sakkas. (2018) Immunotherapy of systemic sclerosis. Human Vaccines & Immunotherapeutics 14:11, pages 2559-2567.
Read now
Read now
Maysoon Eldoma & Janet Pope. (2018) The contemporary management of systemic sclerosis. Expert Review of Clinical Immunology 14:7, pages 573-582.
Read now
Read now
Articles from other publishers (24)
Lazaros I. Sakkas & Theodora Simopoulou. 2023. Translational Autoimmunity. Translational Autoimmunity
447
474
.
Lazaros I. Sakkas & Dimitrios P. Bogdanos. (2022) The Role of T Cells in Systemic Sclerosis: An Update. Immuno 2:3, pages 534-547.
Crossref
Crossref
Masanori Funauchi & Koji Kinoshita. (2022) Problems to Consider Before Determining the Regimen of the Treatment for Juvenile Systemic Sclerosis Treatment: A Case Report Where Tocilizumab Monotherapy Succeeded Efficiently and Safely. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 15, pages 117954412110663.
Crossref
Crossref
Philippe Guilpain, Danièle Noël & Jérôme Avouac. (2021) Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond. Frontiers in Immunology 12.
Crossref
Crossref
Min Liu, Yikai Yu & Shaoxian Hu. (2021) A review on applications of abatacept in systemic rheumatic diseases. International Immunopharmacology 96, pages 107612.
Crossref
Crossref
Ivan Castellví, Muriel Elhai, Cosimo Bruni, Paolo Airò, Suzana Jordan, Lorenzo Beretta, Veronica Codullo, Carlo Maurizio Montecucco, Maria Bokarewa, Florenzo Iannonne, Alexandra Balbir, Vivien M. Hsu, Oliver Distler, Marco Matucci-Cerinic & Yannick Allanore. (2020) Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience. Seminars in Arthritis and Rheumatism 50:6, pages 1489-1493.
Crossref
Crossref
Julie C. Worrell & Steven O'Reilly. (2020) Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis. Journal of Autoimmunity 113, pages 102526.
Crossref
Crossref
Durga Prasanna Misra, Sakir Ahmed & Vikas Agarwal. (2020) Is biological therapy in systemic sclerosis the answer?. Rheumatology International 40:5, pages 679-694.
Crossref
Crossref
Ping Li, Ying Yang, Yi Jin, Rui Zhao, Chen Dong, Wenjie Zheng, Tianyi Zhang, Jing Li & Zhifeng Gu. (2019) B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren’s syndrome. Journal of Translational Medicine 17:1.
Crossref
Crossref
Susanne Schinke & Gabriela Riemekasten. (2019) Systemische SkleroseSystemic sclerosis. Der Internist 60:12, pages 1251-1269.
Crossref
Crossref
Thomas Walsh. (2019) Editor’s Pick: Systemic Sclerosis: The Role of YAP/TAZ in Disease Pathogenesis. European Medical Journal, pages 47-56.
Crossref
Crossref
Rebecca B Blank, Ogonna Kenechi Nwawka, Anna A Yusov & Jessica K Gordon. (2018) Inflammatory arthritis in systemic sclerosis: What to do?. Journal of Scleroderma and Related Disorders 4:1, pages 3-16.
Crossref
Crossref
Gonçalo Boleto, Yannick Allanore & Jérôme Avouac. (2018) Targeting Costimulatory Pathways in Systemic Sclerosis. Frontiers in Immunology 9.
Crossref
Crossref
Yoshihide Asano, Masatoshi Jinnin, Yasushi Kawaguchi, Masataka Kuwana, Daisuke Goto, Shinichi Sato, Kazuhiko Takehara, Masaru Hatano, Manabu Fujimoto, Naoki Mugii & Hironobu Ihn. (2018) Diagnostic criteria, severity classification and guidelines of systemic sclerosis. The Journal of Dermatology 45:6, pages 633-691.
Crossref
Crossref
Robert Pollmann, Thomas Schmidt, Rüdiger Eming & Michael Hertl. (2018) Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches. Clinical Reviews in Allergy & Immunology 54:1, pages 1-25.
Crossref
Crossref
Joana Caetano, Susana Oliveira & José Delgado Alves. 2017. Systemic Sclerosis. Systemic Sclerosis.
A.M. Saracino, C.P. Denton & C.H. Orteu. (2017) The molecular pathogenesis of morphoea: from genetics to future treatment targets. British Journal of Dermatology 177:1, pages 34-46.
Crossref
Crossref
Nóra Legány, László Berta, László Kovács, Attila Balog & Gergely Toldi. (2016) The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary Sjögren’s syndrome and systemic sclerosis. Immunologic Research 65:3, pages 622-629.
Crossref
Crossref
Voon H. Ong & Christopher P. Denton. 2017. Scleroderma. Scleroderma
583
594
.
Matthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, Carole Nicco, Muriel Elhai, Barbara Ruiz, Anne Cauvet, Sonia Pezet, Marie Laure Brandely, Frédéric Batteux, Yannick Allanore & Jérôme Avouac. (2016) Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis. Annals of the Rheumatic Diseases 75:12, pages 2142-2149.
Crossref
Crossref
Catherine H. Orteu & Christopher P. Denton. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
28
.
Florence Roan, Thomas A. Stoklasek, Elizabeth Whalen, Jerry A. Molitor, Jeffrey A. Bluestone, Jane H. Buckner & Steven F. Ziegler. (2016) CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. The Journal of Immunology 196:5, pages 2051-2062.
Crossref
Crossref
R. Eming. (2015) PemphigusPemphigus. Der Hautarzt 66:8, pages 574-582.
Crossref
Crossref
Yohei Kirino & Elaine F. Remmers. (2015) Genetic architectures of seropositive and seronegative rheumatic diseases. Nature Reviews Rheumatology 11:7, pages 401-414.
Crossref
Crossref